Prostate Biopsy with 3D MRI/TRUS Soft Elastic Fusion

Why Choose 3D MRI/TRUS Soft Elastic Fusion Biopsy?

Superior Diagnostic Accuracy

Advanced image fusion technology enables highly precise localization and targeting of MRI-visible lesions, improving diagnostic confidence and reducing sampling errors.

Enhanced Detection of Clinically Significant Prostate Cancer

Targeted biopsy techniques have demonstrated superior performance in identifying clinically significant prostate cancer while reducing the detection of indolent disease.

Access to Difficult-to-Reach Areas

The transperineal approach provides reliable access to anterior, apical, and other anatomically challenging regions of the prostate that may be under-sampled with conventional techniques.

Fewer Biopsy Cores Required

Accurate lesion targeting allows tissue sampling from the areas most likely to harbor clinically significant disease, minimizing the number of biopsy cores required.

Reduced Risk of Infection

Unlike traditional transrectal biopsy, the transperineal technique avoids needle passage through the rectal wall, substantially lowering the risk of infectious complications, including post-biopsy sepsis.

Performed Under Local Anesthesia

The procedure is well tolerated and can be safely performed under local anesthesia without the need for general anesthesia or hospitalization.

Minimal Patient Discomfort

Modern transperineal biopsy techniques are associated with excellent patient tolerance and rapid recovery.

Rapid Return to Daily Activities

Most patients can resume their normal activities shortly after completion of the procedure.

International Standard of Care

Current recommendations from the European Association of Urology (EAU), the American Urological Association (AUA), and the National Comprehensive Cancer Network (NCCN) support the use of multiparametric MRI prior to biopsy and emphasize the value of MRI-targeted biopsy for the detection of clinically significant prostate cancer.

Growing scientific evidence has established MRI/Ultrasound Fusion Biopsy as a preferred diagnostic strategy due to its superior sensitivity, specificity, and diagnostic yield compared with conventional systematic biopsy techniques.

Furthermore, a major international shift toward the transperineal approach has emerged in recent years because of its markedly lower infection rates and improved access to all regions of the prostate. This evolution has led many centers of excellence worldwide to progressively replace the traditional transrectal biopsy pathway.

Koelis Trinity® Perine

Precision Navigation Technology for Advanced Prostate Diagnostics

The Koelis Trinity® Perine platform integrates cutting-edge imaging, navigation, and tracking technologies to deliver exceptional diagnostic precision.

Key capabilities include:

• Real-time Soft Elastic Fusion of multiparametric MRI and three-dimensional ultrasound images.
• Organ-Based Tracking Fusion (OBT Fusion®) technology for highly accurate lesion localization and targeting.
• Three-dimensional visualization and reconstruction of prostate anatomy.
• Real-time targeted biopsy guidance and navigation.
• Comprehensive digital mapping of all biopsy cores and sampled locations.
• Longitudinal storage and retrieval of biopsy data, facilitating future surveillance, repeat biopsy planning, focal therapy guidance, and treatment decision-making.

National Leadership in Transperineal Fusion Biopsy

IATROPOLIS Medical Group is the only healthcare provider in Greece offering Transperineal Soft Elastic Fusion Biopsy under Local Anesthesia utilizing the Koelis Trinity® Perine platform.

This unique capability combines advanced technology, subspecialized urological expertise, and evidence-based clinical practice to provide patients with one of the most accurate and safest prostate cancer diagnostic pathways currently available.

Excellence in Prostate Cancer Diagnosis

At IATROPOLIS Medical Group, we are committed to delivering precision medicine through innovation, expertise, and adherence to internationally recognized clinical standards. Our goal is to provide every patient with the highest level of diagnostic accuracy, safety, and personalized care in the evaluation of suspected prostate cancer.

Suggested References

• European Association of Urology — Prostate Cancer Guidelines.
• American Urological Association / Society of Urologic Oncology Clinical Practice Guidelines.
• National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Prostate Cancer Early Detection.
• TRexit Initiative.
• European Society of Urogenital Radiology PI-RADS v2.1 Recommendations.